Building tomorrow’s facilities, today

Building tomorrow’s facilities, today

Mar 12, 2019

Celebrating 40 years, INTERPHEX has been, and continues to be, the premier pharmaceutical, biotechnology, and device development and manufacturing event where you can “Experience Science through Commercialization”. Sponsored by the Parenteral Drug Association (PDA), the event is based in New York and brings over 10,500 global industry professionals and 620+ industry leading suppliers together to “Learn it, Experience it, Procure it” through a unique combination of no cost technical conference, exhibits, demonstrations, roundtables, partnering opportunities and networking to leverage quality, efficiency and cost effectiveness in today’s ever-changing global market.

INTERPHEX is being held April 2-4, 2019 at the Javits Center in New York and we are excited to see old faces and meet new friends! Be sure to stop by and say hello (#2725), especially for happy hour on Wednesday from 3:00 pm – 5:00 pm.

Advanced & Highly Adaptive Automation Technology Integrated with Industry 4.0 Trends
04/03/2019, 10:00 AM – 10:45 AM
INTERPHEX Live Crystal Palace Lobby
Speakers: Yvonne Duckworth (CRB) and Steve Madruga (Kinetics)

Tech Tank – NextGen Now.
The biotechnology industry requires sophisticated, mixed-use facilities for product development, manufacturing, and distribution. Learn from CRB experts as they share their knowledge on the future of cell and gene therapy, state-of-the-art phase 3 gene therapy manufacturing facilities and isolation technologies for cell and gene therapy.

Isolators for Cell and Gene Therapy
04/02/2019, 3:15 PM – 4:00 PM
Stage 1, Booth 1076, Exhibit Hall
Speakers: Christa Myers, Todd Vaughn and Kevin Kyle (Germ Free)

The industry is changing fast in the cell and gene therapy arena. Producers are changing their approach from biosafety cabinets to isolators. CRB’s aseptic processing and project delivery specialists Christa Myers and Todd Vaughn will discuss the drivers for “why isolators,” the configurations available and how to plan your project to identify, reduce and avoid the risks associated with the processing steps. Germfree Laboratories’ president, Kevin Kyle, will present with CRB on how to take a process from “ready to use” into an “operations ready” facility. Why, how and when you should be planning your next project may surprise you.

From Blank Paper to a State of the Art Phase 3 / Commercial Gene Therapy Manufacturing Facility
04/02/2019, 2:15 PM – 3:00 PM
Stage 1, Booth 1076, Exhibit Hall
Speakers: Matt Khair (CRB) and Paragon

Paragon Bioservices Inc., a biologics Contract Development and Manufacturing Organization (CDMO) located in downtown Baltimore, has been experiencing considerable growth due to their experience and client demand in the gene therapy and vaccines market. This growth has led the company to expand into a newly constructed building located in nearby Harmons, MD. The new building provided Paragon with a unique opportunity to quickly design, construct and qualify a new GMP manufacturing facility while also providing the necessary space to grow GMP warehouse, administrative, laboratory and support functions. In response to their clients’ needs, Paragon required this fully flexible manufacturing facility and associated spaces to be constructed in less than 10 months from project initiation. Working closely with CRB and their AEC partner, the team was able to design and construct a multi-product, multi-process facility predicated on maximum flexibility and adaptability, while prioritizing segregation between manufacturing suites to maintain low risk of any cross contamination and protecting client confidentiality. Hear how this partnership between owner and A/E/C married IPD into an aggressive timeline to improve the speed to market.

Evolution of the Revolution: The Future of Cell and Gene Therapy
04/02/2019, 1:15 PM – 2:00 PM
Stage 1, Booth 1076, Exhibit Hall
Speakers: Noel Maestre (CRB) and Peter Walters (CRB)

Advanced therapy medicinal product processes have fallen back on manual operations to accommodate the patient-specific scale, but what will these facilities look like in five years? The race for process closure and automated solutions has already begun. Don’t miss out as CRB’s Peter Walters and Noel Maestre discuss what will drive the industry to lower operating costs, more efficient use of staff and improved reliability and product reproducibility.

For more information: